Innovative Pharmaceutical Biotech Limited has announced the placement of new shares under a general mandate. The company, listed on the Hong Kong Stock Exchange with the stock code 399, plans to allot, issue, and deal with new shares, not exceeding 20% of the existing issued shares, as per the mandate granted at the company's annual general meeting. The maximum number of shares to be issued is 344,638,604. Completion of the placement is contingent upon the fulfillment of specified conditions outlined in the Placing Agreement, and the process may or may not proceed. Shareholders and potential investors are advised to exercise caution when dealing with the company's shares and securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.